QR678 Hair Regrowth Therapy at NURIM Dermatech is a personalized hair treatment approach designed to support hair follicles, hair growth and healthier-looking hair.
“Regeneration is a biological process – and biological processes require time.”

Hair is an expression of identity, confidence and individuality. When hair begins to thin or lose its natural density, the change can extend far beyond the scalp. QR678 therapy is designed as regenerative progressive approach designed to support the scalp environment, revitalise compromised hair follicles, and improve the appearance of hair density and quality.
At Nurim, QR678 focuses on supporting the biology of existing follicles rather than simply masking the appearance of thinning hair – offering a progressive, minimally invasive approach to improving the quality and appearance of hair. QR678 therapeutically centred on supporting viable hair follicles and their surrounding microenvironment, rather than creating new follicles or replacing surgically transplanted follicles.
QR678 and hair transplantation serve different purposes.
QR678 is a minimally invasive regenerative treatment intended to support existing follicles and improve the quality and appearance of thinning hair.
Hair Transplantation involves surgically relocating hair follicles from a donor area to areas of reduced density.
For some patients, regenerative therapy may be considered as part of broader hair-restoration strategy, including before or after transplantation, depending on clinical suitability.
Every QR678 session at Nurim Dermatech is designed around your individual scalp condition and hair-restoration goals. The procedure is performed with meticulous precision to ensure targeted delivery and maximum comfort.
A detailed evaluation of your hair-loss pattern, scalp health, follicular condition, and hair density is performed to determine your suitability for QR678 therapy.
The scalp is gently cleansed and prepared under appropriate clinical conditions. A topical or local anaesthetic may be used when required to enhance comfort.
QR678 is administered through a series of carefully placed micro-injections across the areas of thinning or reduced density. The treatment is performed with controlled precision to target the desired scalp regions.
Once delivered, the specialised formulation is intended to support the local follicular environment and biological signalling associated with healthy hair growth.
The scalp is assessed following the procedure, and personalised aftercare instructions are provided to support optimal recovery.
QR678 is typically performed as a planned series of sessions rather than a single treatment. Your progress is monitored clinically, allowing the treatment protocol to be refined according to your individual response.
QR678 is a minimally invasive regenerative hair therapy designed to provide targeted regenerative support to the scalp and existing hair follicles. A spart of a personalised hair-restoration protocol, it focuses on improving the follicular environment and support the scalp and existing hair follicles, with the goal of improving hair quality and the appearance of density over time. Its benefits are –
QR678 is a minimally invasive intradermal scalp procedure. As with any injectable treatment, transient local reactions may occur following administration.
Adverse effects are as –
QR678 may not be appropriate in the following circumstances:
A minimally invasive injectable therapy designed to support existing hair follicles and the scalp environment.
Individuals with suitable patterns of hair thinning or follicular miniaturisation.
No. it is a non-surgical regenerative hair therapy.
Mild discomfort may occur, anaesthetic measures can be used for comfort.
The treatment schedule is personalised according to individual clinical needs.
Usually minimal, although temporary redness, swelling, or tenderness may occur.
Results vary, and ongoing hair-loss management may be required.
It may be considered when viable follicles remain and clinical assessment supports treatment.
It may improve the calibre and appearance of miniaturised hair in responsive patients.
Yes, when clinically indicated and appropriately assessed.
Small injection-site marks, redness, swelling, or bruising may temporarily occur.
It may be considered as part of post-transplant hair management when clinically appropriate.
No. Effectiveness depends on the underlying diagnosis and viability of the hair follicles.
Yes. A clinical assessment is essential for suitability and treatment goals.